Meta tags:
author= ESMO;
keywords= medical oncology,oncologists,oncology societies,oncology conferences,europe;
description= ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.;
Headings (most frequently used words):
esmo, 2024, in, cancer, to, of, and, with, the, for, congress, on, cancers, oncology, rare, new, treatment, patients, preceptorship, attend, or, promise, are, benefit, care, reasons, lung, metastatic, screening, indications, should, gastrointestinal, 2023, studies, combination, you, two, pembrolizumab, breast, sarcoma, fellowship, not, colorectal, fda, be, course, next, approves, urothelial, provide, health, your, advanced, tumour, stage, evidence, european, lugano, now, shows, nsclc, medical, targeted, from, increasing, large, meaningful, palliative, clinically, demonstrate, continues, who, adjuvant, carcinoma, research, show, supportive, unresectable, resected, gemcitabine, nivolumab, helsinki, use, tests, dmfs, active, call, non, society, register, america, latin, summit, immuno, ichno, december, iib, manifesto, other, work, this, an, eu, therapeutic, plan, award, iic, melanoma, cisplatin, recipient, stable, different, as, imatinib, also, continued, support, state, further, disease, early, steps, gep, why, still, sarcomas, necs, can, what, centralisation, gist, life, tumours, announced, women, treatments, career, desmoid, types, nirogacestat, quality, clinical, niche, improves, localized, art, malignancies, education, meetings, sao, best, options, bladder, strategies, paulo, courses, journals, publications, subscribe, kidney, perioperative, day, up, areas, gender, equity, advancing, commission, lancet, partners, people, vaccination, outlining, key, 19, directions, covid, statements, three, wake, twenty, releases, renewed, unleash, been, potential, beating, universal, coverage, study, availability, anti, medicines, must, future, their, hong, 172, students, applying, submit, become, member, membership, 35k, collaboration, 40, powerful, give, others, jordan, apply, 2026, cervantes, thinking, would, like, post, examination, by, offered, looking, esmobreast24, path, improve, development, community, international, top, dent, collaborate, kong, medicine, invitation, gallery, video, workshop, methods, essen, nuclear, maio, applications, diagnostic, eanm, valencia, china, sar, president, marabelle, network, legal, opportunity, excellent, event, at, experience, share, kfoury, bayona, sanchez, esmogynae24, useful, links, invite, svane, has, obesity, relations, phaeochromocytomas, chemotherapy, compared, vedotin, enfortumab, survival, paragangliomas, sunitinib, untreated, efficacy, resectable, neoadjuvant, include, extension, recommends, previously, locally, diagnosis, cell, naïve, os, prolong, does, resection, primary, small, amivantamab, mutated, insertion, 20, exon, egfr, vmjw, ema, after, colon, may, resources, webinar, practice, mtb, mcbs, finland, 23, news, 22, abstracts, plenaries, virtual, academy, elcc, latest, brca, sexual, analysis, poor, report, most, immunotherapy, response, monitoring, biopsy, mutations, liquid, multimodal, mcrpc, outcomes, worse, associated, iv, amenable, official, countries, enters, survivors, rights, financial, equal, ensure, calls, heine, forgotten, right, policy, public, effective, into, era, translating, chair, actor, status, special, honorary, tat, appointments, groups, hansen, working, committees, open, awards, process, nomination, scientific, singapore, curative, syndrome, 26, therapies, anticancer, capecitabine, oral, treated, foot, february, hand, incidence, reduces, gel, diclofenac, topical, 28, paris, adults, asia, switzerland, geneva, young, france, among, rates, bowel, increases, contributing, alcohol, newsletters,
Text of the page (most frequently used words):
#esmo (208), the (146), 2024 (109), and (99), #cancer (87), for (65), #oncology (62), covid (40), #cancers (39), mar (37), #with (33), #congress (29), #society (28), 2023 (27), #rare (27), #care (24), news (22), updates (20), daily (19), reporter (19), clinical (18), working (18), from (17), press (17), group (17), patients (17), research (16), committee (16), award (15), treatment (15), all (15), era (14), preceptorship (14), courses (13), study (13), lung (13), more (13), releases (13), feb (12), medical (12), about (12), guidelines (12), your (12), are (12), studies (11), now (11), european (11), open (11), course (10), sarcoma (10), world (10), our (10), mcbs (9), advanced (9), malignancies (9), meeting (9), 2022 (9), this (9), policy (8), can (8), palliative (8), events (8), cookies (8), new (8), patient (8), metastatic (8), breast (8), may (8), benefit (8), task (8), evidence (8), funding (8), findings (8), tumours (8), that (8), early (8), pandemic (7), class (7), supportive (7), fellowship (7), use (7), force (7), registration (7), two (7), promise (7), gastrointestinal (7), online (7), health (7), jul (7), 2019 (7), event (7), sessions (7), member (7), scientific (7), how (7), day (7), benefits (7), you (7), lugano (7), tumour (7), resources (7), their (6), attend (6), lymphoma (6), not (6), haematological (6), cell (6), primary (6), non (6), young (6), experts (6), analysis (6), reasons (6), site (6), centres (6), latest (6), development (6), melanoma (5), pembrolizumab (5), head (5), medicines (5), journals (5), jan (5), medicine (5), urothelial (5), should (5), carcinoma (5), career (5), state (5), during (5), gist (5), neck (5), oncologists (5), after (5), meetings (5), annals (5), 2021 (5), membership (5), board (5), members (5), virtual (5), based (5), results (5), will (5), who (5), efficacy (5), different (5), women (5), facebook (5), immuno (5), announcement (5), give (4), exam (4), questions (4), webinar (4), groups (4), shows (4), management (4), nsclc (4), roundtable (4), asia (4), work (4), opportunities (4), specialists (4), testimonials (4), demonstrate (4), resected (4), combination (4), its (4), chemotherapy (4), examination (4), further (4), sources (4), support (4), improve (4), colorectal (4), read (4), apply (4), indications (4), educational (4), release (4), discover (4), oct (4), switzerland (4), targeted (4), designated (4), calling (4), general (4), public (4), anticancer (4), annual (4), action (4), why (4), screening (4), call (4), announced (4), genitourinary (4), register (4), series (4), field (4), imatinib (4), second (3), bladder (3), paulo (3), fda (3), w4o (3), sao (3), stage (3), tools (3), next (3), coverage (3), increasing (3), practice (3), also (3), provide (3), best (3), prostate (3), december (3), nomination (3), settings (3), burden (3), pocket (3), track (3), dec (3), discuss (3), present (3), resilience (3), therapies (3), resource (3), faqs (3), education (3), 2020 (3), centre (3), treated (3), calendar (3), publications (3), key (3), achievements (3), app (3), march (3), awards (3), manifesto (3), process (3), europe (3), major (3), approves (3), plenaries (3), precision (3), outcomes (3), programme (3), calls (3), innovative (3), sarcomas (3), held (3), post (3), has (3), treatments (3), leaders (3), get (3), acknowledgements (3), collaborate (3), prominent (3), phase (3), essential (3), become (3), reference (3), editorial (3), molecular (3), hodgkin (3), oncologypro (3), trial (3), life (3), following (3), worldwide (3), diagnosis (3), multiple (3), reported (3), into (3), login (3), first (3), contact (3), what (3), change (3), tests (3), other (3), global (3), helsinki (3), summit (3), partners (3), observatory (3), high (3), president (3), myeloma (3), hansen (3), neuroendocrine (3), heine (3), gynaecological (3), survival (3), academy (3), spain (3), eha (3), art (3), application (3), risk (3), final (3), students (3), information (3), tat (3), glossary (3), current (3), honorary (3), durante (2), aggressive (2), right (2), cervical (2), personalised (2), pandemia (2), explained (2), survivors (2), france (2), small (2), challenges (2), endometrial (2), time (2), forgotten (2), financial (2), brain (2), climate (2), guides (2), madrid (2), save (2), advances (2), still (2), improves (2), nirogacestat (2), desmoid (2), occurring (2), was (2), symptom (2), reduction (2), defi (2), hoc (2), niche (2), place (2), stable (2), efforts (2), sustaining (2), steps (2), centralisation (2), expedite (2), implementation (2), collaborations (2), border (2), cross (2), increased (2), quality (2), disease (2), continued (2), gep (2), immunotherapy (2), access (2), solid (2), response (2), genomics (2), most (2), suggests (2), guided (2), sexual (2), necs (2), failure (2), explore (2), gastroenteropatic (2), carcinomas (2), effect (2), synergic (2), irinotecan (2), lurbinectedin (2), types (2), active (2), realised (2), theranostics (2), adcs (2), models (2), optimise (2), scale (2), hub (2), live (2), abstracts (2), gain (2), immediate (2), visibility (2), unknown (2), together (2), paris (2), advocates (2), past (2), adults (2), among (2), rce (2), rates (2), predict (2), geneva (2), nov (2), mission (2), april (2), until (2), uninterrupted (2), checkmate (2), show (2), large (2), blue (2), eclipse (2), unresectable (2), gemcitabine (2), cisplatin (2), nivolumab (2), 901 (2), iic (2), magnitude (2), iib (2), dmfs (2), meaningful (2), clinically (2), continues (2), adjuvant (2), 716 (2), keynote (2), free (2), metastasis (2), distant (2), hepatocellular (2), knowledge (2), committees (2), countries (2), host (2), include (2), workshops (2), institutes (2), fellowships (2), assembly (2), external (2), code (2), session (2), consensus (2), structure (2), recommendations (2), executive (2), elections (2), corner (2), summits (2), faculty (2), recertification (2), requirements (2), years (2), five (2), over (2), translational (2), rights (2), terms (2), newsletters (2), useful (2), workshop (2), availability (2), national (2), universal (2), digital (2), data (2), potential (2), apr (2), finland (2), therapeutic (2), applications (2), essen (2), germany (2), valencia (2), america (2), latin (2), future (2), hong (2), kong (2), sar (2), china (2), brazil (2), real (2), frequently (2), fellow (2), community (2), plan (2), asked (2), ichno (2), submit (2), forces (2), handbooks (2), slide (2), sets (2), cme (2), out (2), fesmo (2), statements (2), special (2), interest (2), some (2), search (2), privacy (2), ecro (2), vaccines (2), browser (2), vaccination (2), today (2), people (2), pleased (2), announce (2), grants (2), status (2), properly (2), relations (2), official (2), actor (2), these (2), bestowed (2), necessary (2), values (2), renal (2), act (2), others (2), generation (2), experience (2), help (2), gender (2), recipient (2), worse, joining, widest, mtb, oops, join, shoes, page, stepping, categories, footprint, letter, associated, mutations, possible, audience, fees, topic, country, chest, features, mcrpc, expert, understand, version, neuro, assess, chrome, hereditary, using, old, paga, syndromes, endocrine, boards, adaptation, methodologies, asian, sequencing, tool, sep, logo, one, minimal, form, involved, 2025, communication, societies, leadership, iotech, practising, vision, accreditation, opwg, siog, accessible, elderly, adolescents, compliance, audit, council, organisational, lifetime, achievement, seamonkey, declaration, brand, notification, leukemia, reviews, affiliated, google, firefox, nominations, validated, technology, careers, biographies, mozilla, disclosure, reproducible, vote, bylaws, explorer, conduct, internet, opera, safari, apple, faq, efpia, pan, pathways, methodology, jobs, advocacy, line, language, scales, travel, bone, 2018, effects, side, 2017, survivorship, pain, 2016, oncologist, getting, grant, pool, definition, corporate, governance, considering, parallel, sit, talent, certificate, sample, actionability, targets, mora, professional, escat, schemes, cuidado, abroad, pandémie, oesophageal, ovarian, pancreatic, krebstherapie, während, der, pandemie, accredit, integrated, databases, type, database, regulatory, training, cours, del, cure, cáncer, bureaucracy, rationalizing, procedures, bibliography, per, proposals, cancro, traitement, list, families, mobile, nhl, student, sponsors, congresses, elsevier, perspectives, experiences, kols, surveys, registries, registry, cocare, tutorials, adapted, indolent, gastro, weighing, topics, translated, disclaimer, hcc, mcl, update, approaches, dlbcl, therapy, elcc, miss, important, aug, masterclasses, risks, specific, kick, 2030, agenda, involvement, activities, consultations, yo4yo, childcare, responses, policies, networks, jarc, service, portal, off, survey, reorganising, roundtables, wave, eso, known, symposia, unknowable, colloquia, licensed, awardees, full, media, newsroom, offers, joint, reports, brca, moving, personalise, clinicians, czech, republic, prague, visit, library, factsheet, biomarkers, essentials, range, kidney, browsed, downloaded, offline, tech, globally, visible, platform, barcelona, directions, source, netherlands, marabelle, svane, invite, invitation, video, gallery, methods, sint, localized, michielsgestel, jun, eanm, diagnostic, nuclear, berlin, perioperative, strategies, publish, preceptorships, share, beating, centred, approach, close, gap, healthier, outlining, areas, unleash, advisor, must, lancet, commission, advancing, equity, available, they, address, safety, wake, anti, lectures, leading, interactive, discussion, seminars, supporting, decisions, regularly, updated, developed, profession, last, options, observes, anticipates, costs, accessibility, antineoplastic, highlighting, worrying, stall, maio, kfoury, advocate, registered, being, used, instagram, linkedin, rss, youtube, twitter, swiss, profit, providing, organisation, provided, directly, via, ginevra, 6900, copyright, insights, while, sign, disable, enable, core, functionality, website, cannot, function, without, only, them, uses, changing, preferences, accept, reject, customise, detailed, please, check, reserved, receive, bayona, cervantes, watch, videos, esmobreast24, top, international, collaboration, 2026, dent, institutions, jordan, powerful, excellent, opportunity, network, esmogynae24, sanchez, path, chance, account, 172, subscribe, links, cookie, legal, specialties, professionals, 35k, thinking, collegial, applying, main, saturday, october, looking, offered, would, like, participate, interference, strategy, testing, resection, incidence, hand, foot, syndrome, oral, capecitabine, synchronous, ccre, does, gel, prolong, naïve, colon, amenable, curative, papillon, amivantamab, reduces, diclofenac, egfr, bring, stakeholder, focuses, novel, transform, impact, february, renowned, topical, researchers, practitioners, appointment, brings, various, thoracic, torch, vmjw, exon, bowel, fragment, concerns, often, unaddressed, report, poor, kinetics, dna, methylation, quantity, resectable, plasma, multimodal, liquid, biopsy, monitoring, castration, resistant, genetic, however, neoadjuvant, insertion, locally, mutated, 302, enfortumab, vedotin, compared, previously, untreated, firstmappp, extension, sunitinib, phaeochromocytomas, paragangliomas, indicated, adult, recurrence, ema, recommends, multi, increases, booster, target, mandates, january, chair, appointments, enriqueta, felip, likely, drugs, alterations, chairs, cells, less, need, landmark, trials, late, breaking, presentations, started, appointed, opens, organisations, dose, twenty, three, renewal, organization, privilege, granted, governmental, which, newly, recognises, sustained, systematic, engagement, been, renewed, funda, meric, bernstam, enters, doors, contributing, where, across, entire, relevance, level, specifically, pacific, region, singapore, developments, translating, fast, selected, between, component, death, obesity, alcohol, effective, biggest, week, guaranteeing, states, recently, adopted, text, consumer, credits, directive, neighbours, seeking, tackle, credit, called, period, end, ensure, equal, building, strong, political, displaying,
Text of the page (random words):
nd aggressive t cell lymphoma in the second phase of the covid 19 pandemic esmo eha haematological malignancies hodgkin lymphoma in the second phase of the covid 19 pandemic esmo eha haematological malignancies indolent b nhl in the second phase of the covid 19 pandemic esmo eha haematological malignancies multiple myeloma in the covid 19 era head and neck cancers in the covid 19 era melanoma in the covid 19 era sarcomas in the covid 19 era supportive care in the covid 19 era covid 19 adapted recommendations slide sets esmo mcbs esmo mcbs sessions at esmo 2020 esmo mcbs online tutorials esmo mcbs in action about the esmo mcbs esmo mcbs for solid tumours esmo mcbs for haematological malignancies esmo mcbs terms of use meetings meeting calendar past meetings esmo congresses esmo virtual plenaries abstracts sponsors faqs esmo academy esmo advanced courses faqs acknowledgements testimonials esmo preceptorship courses acknowledgements faqs testimonials esmo summits testimonials esmo courses in medical oncology for medical students esmo best student award testimonials eso esmo masterclasses esmo symposia esmo colloquia esmo webinar series workshops courses esmo events app how to use the app esmo licensed events career development oncology fellowships host institutes host an esmo fellow fellowship offers benefits for institutes awardees and reports external oncology fellowship opportunities about oncology fellowships resilience task force esmo resilience task force survey series young oncologists corner young oncologists track childcare service yo4yo virtual session series about young oncologists corner national activities considering a career abroad esmo examination parallel sessions why sit the esmo exam esmo exam talent pool sample exam questions explained best exam award recertification cme esmo mora recertification process and requirements cme tests for handbooks esmo certificate of professional development esmo advanced courses esmo preceptorship courses esmo webinar series esmo virtual plenaries jobs in oncology women for oncology esmo w4o observatory w4o hub resource centre w4o sessions and events leaders generation programme class of 2021 2022 class of 2016 class of 2017 class of 2018 class of 2019 leaders generation programme asia class of 2019 class of 2022 travel grants for esmo meetings about career development scales and tools research about the grant schemes esmo clinical research observatory task force ecro acknowledgements rationalizing bureaucracy bibliography on clinical trial procedures research funding opportunities esmo webinar eu research opportunities how to apply for eu grants eu calls for proposals training and events regulatory information other research funding opportunities research groups tools and database general research groups cancer research groups by type databases research tools for patients resources for patients with cancer esmo designated centres of integrated oncology and palliative care palliative and supportive care sessions at esmo congress 2022 paris how to re accredit designated centres working group palliative and supportive care sessions at esmo congress 2023 madrid 2023 esmo designated centres cancer care during the covid 19 pandemic multiple myeloma melanoma sarcoma krebstherapie während der covid 19 pandemie renal cell carcinoma prostate cancer pancreatic cancer lung cancer ovarian cancer supportive care glossary palliative care glossary gastro oesophageal cancer hepatocellular carcinoma endometrial cancer colorectal cancer primary brain tumour aggressive lymphoma management breast cancer b cell non hodgkin lymphoma urothelial bladder cancer hodgkin lymphoma cervical cancer traitement du cancer au cours de la pandémie de covid 19 le cure per il cancro durante la pandemia da covid 19 cuidado del cáncer durante la pandemia de covid 19 glossary patient advocates working group patient advocacy track patient guides patient guides by language bone health in cancer immunotherapy side effects survivorship cancer pain management personalised cancer medicine personalised medicine explained getting the most out of your oncologist policy esmo scale for clinical actionability of molecular targets escat esmo public policy track and special sessions esmo public policy committee esmo manifesto rare cancers working group about rare cancers working group our mission our governance our partners our corporate partners contact us what are rare cancers definition of rare cancers families and list of rare cancers specific challenges of rare cancers rare cancers in europe rare cancer agenda 2030 the rare cancers working group involvement in eu policy rce s responses to eu public consultations rare cancers europe s call to action on rare cancers in all policies european reference networks rce jarc about the rare cancer treatment portal news events joint action on rare cancers kick off meeting past events policy news cancer medicines committee patient advocates working group major achievements newsroom press and media hub esmo daily reporter oncology news esmo society updates covid 19 and cancer covid 19 vaccination covid 19 full coverage news in covid 19 esmo live roundtables esmo facebook roundtable covid 19 vaccines and cancer care the known the unknown and the unknowable esmo facebook roundtable covid 19 vs cancer reorganising cancer care after the first wave esmo facebook roundtable covid 19 vs cancer the future of cancer research esmo facebook roundtable covid 19 vs cancer weighing up risks over time covid 19 useful resources elsevier resource centre on covid 19 kols experiences perspectives registries studies and surveys esmo cocare registry covid 19 resource centre cancer patient management during the covid 19 pandemic cancer care during the covid 19 pandemic covid 19 palliative care pathways covid 19 and cancer care in the esmo journals q a on covid 19 become a member login early registration early registration esmo gastrointestinal cancers congress 2024 4 aug 2023 esmo gi 2024 scientific committee members and gi experts give their reasons why you should not miss this important event register by 10 april and save calling all lung cancer specialists calling all lung cancer specialists elcc 2024 register now 17 oct 2022 the current state of the art in lung cancer therapy registration calling all head and neck cancer specialists calling all head and neck cancer specialists ichno 2024 register now 18 jul 2022 innovative approaches in head and neck oncology registration registration open registration open esmo academy 2024 5 jul 2023 registration for the esmo academy 2024 is now open get your update on the key topics in medical oncology register now gain immediate visibility worldwide gain immediate visibility worldwide esmo virtual plenaries call for abstracts 21 jul 2023 present your latest cancer research to the widest possible audience in our live online sessions submit by 5 april esmo courses esmo preceptorship on nsclc 22 23 may 2024 helsinki finland online application is open until 19 march 2024 apply now esmo courses esmo preceptorship on supportive and palliative care 2024 lugano online application is open until 27 march 2024 apply now 11 jul 2019 esmo mcbs a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines discover more meeting resources are now online meeting resources are now online esmo sarcoma and rare cancers congress 2024 18 sep 2023 access the meeting resources precision oncology genomics guided care precision oncology genomics guided care mtb in clinical practice webinar resources 18 feb 2022 understand the clinical and scientific applications of the molecular tumour boards for different methodologies in tumour sequencing access now latest news daily reporter all news oncology news press releases society updates daily reporter a new combination treatment shows early promise in gep necs 16 mar 2024 lurbinectedin and irinotecan demonstrate a synergic clinical effect in patients with neuroendocrine carcinomas of gastroenteropatic primary site after chemotherapy failure daily reporter can sarcomas benefit from targeted treatments active in other tumour types 15 mar 2024 two studies in sarcoma explore the promise of adcs and theranostics realised in different tumours daily reporter desmoid tumours nirogacestat improves quality of life also in stable disease 15 mar 2024 in a post hoc analysis of the defi trial a reduction in symptom burden was reported with benefits occurring early in treated patients daily reporter should rare cancers still be in a niche of oncology 15 mar 2024 esmo is sustaining its efforts to give rare cancers a more prominent place in oncology daily reporter centralisation of care in rare cancers what are the next steps 14 mar 2024 innovative models and increased cross border collaborations can further support the implementation of rare cancer reference centres to expedite diagnosis and improve treatment daily reporter studies provide further evidence to support continued imatinib in two different gist indications 14 mar 2024 uninterrupted imatinib is essential to optimise outcomes in metastatic and high risk resected gist daily reporter brca mutations are associated with worse treatment outcomes in mcrpc 8 mar 2024 in patients with metastatic castration resistant prostate cancer early genetic testing may help personalise treatments in the first line as a study suggests daily reporter a multimodal liquid biopsy analysis shows promise in monitoring response to immunotherapy 5 mar 2024 a study shows that early kinetics in dna methylation and fragment quantity in plasma can predict response to pembrolizumab in patients with advanced solid tumours daily reporter most women report poor sexual health after a diagnosis of breast cancer 1 mar 2024 however patients sexual concerns are often unaddressed in oncology a study suggests read the esmo daily reporter oncology news two large studies with new screening tests show promise for increasing the use of colorectal cancer screening 18 mar 2024 findings from the eclipse and blue c studies daily reporter a new combination treatment shows early promise in gep necs 16 mar 2024 lurbinectedin and irinotecan demonstrate a synergic clinical effect in patients with neuroendocrine carcinomas of gastroenteropatic primary site after chemotherapy failure oncology news fda approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma 15 mar 2024 evidence for efficacy is based on the results from the checkmate 901 study daily reporter can sarcomas benefit from targeted treatments active in other tumour types 15 mar 2024 two studies in sarcoma explore the promise of adcs and theranostics realised in different tumours daily reporter desmoid tumours nirogacestat improves quality of life also in stable disease 15 mar 2024 in a post hoc analysis of the defi trial a reduction in symptom burden was reported with benefits occurring early in treated patients daily reporter should rare cancers still be in a niche of oncology 15 mar 2024 esmo is sustaining its efforts to give rare cancers a more prominent place in oncology daily reporter centralisation of care in rare cancers what are the next steps 14 mar 2024 innovative models and increased cross border collaborations can further support the implementation of rare cancer reference centres to expedite diagnosis and improve treatment daily reporter studies provide further evidence to support continued imatinib in two different gist indications 14 mar 2024 uninterrupted imatinib is essential to optimise outcomes in metastatic and high risk resected gist oncology news adjuvant pembrolizumab continues to demonstrate a clinically meaningful dmfs benefit in patients with resected stage iib or iic melanoma 14 mar 2024 findings from the final distant metastasis free survival analysis of keynote 716 study read the esmo daily reporter more oncology news more press releases more society updates oncology news two large studies with new screening tests show promise for increasing the use of colorectal cancer screening 18 mar 2024 findings from the eclipse and blue c studies oncology news fda approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma 15 mar 2024 evidence for efficacy is based on the results from the checkmate 901 study oncology news adjuvant pembrolizumab continues to demonstrate a clinically meaningful dmfs benefit in patients with resected stage iib or iic melanoma 14 mar 2024 findings from the final distant metastasis free survival analysis of keynote 716 study oncology news ema recommends extension of therapeutic indications for pembrolizumab to include neoadjuvant treatment of resectable nsclc 13 mar 2024 it is indicated in adult patients at high risk for recurrence oncology news efficacy of sunitinib in patients with metastatic phaeochromocytomas and paragangliomas 12 mar 2024 findings from the firstmappp study oncology news survival benefit of enfortumab vedotin and pembrolizumab compared with chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer 11 mar 2024 findings from the ev 302 study oncology news fda approves amivantamab vmjw for egfr exon 20 insertion mutated non small cell lung cancer indications 8 mar 2024 evidence for efficacy is based on the results from the papillon study oncology news primary tumour resection does not prolong os in patients with treatment naïve stage iv colon cancer not amenable for curative treatment 7 mar 2024 findings from the analysis of synchronous and ccre iv studies oncology news topical diclofenac gel reduces the incidence of hand foot syndrome in patients treated with oral capecitabine 6 mar 2024 findings from the d torch study more oncology news press releases event announcement european lung cancer congress 2024 7 mar 2024 the european lung cancer congress 2024 is the annual appointment that brings together various experts in the field of thoracic oncology press releases event announcement esmo sarcoma and rare cancers congress 2024 5 mar 2024 the esmo sarcoma and rare cancers congress 2024 will be held in lugano from 14 to 16 march and will bring together world renowned experts among researchers and practitioners to present and discuss the latest advances in the treatment and care of sarcoma and rare cancers in general press releases event announcement esmo targeted anticancer therapies congress 2024 26 28 february paris france 20 feb 2024 the esmo targeted anticancer therapies congress 2024 is the annual multi stakeholder meeting that focuses on the development of novel anticancer therapies and how this can transform the current knowledge and impact clinical care press releases annals of oncology press release obesity and alcohol are contributing to increases in bowel cancer rates among young adults 29 jan 2024 experts predict death rat...
|